Thomas Frank Gajewski
University of Chicago · 654 works · 57,236 citations · h-index 98
Top works
- Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones.
- Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
- PD-L1/B7H-1 Inhibits the Effector Phase of Tumor Rejection by T Cell Receptor (TCR) Transgenic CD8+ T Cells
- Up-Regulation of PD-L1, IDO, and T regs in the Melanoma Tumor Microenvironment Is Driven by CD8 + T Cells
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
- Helper T Cell Differentiation Is Controlled by the Cell Cycle
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
- Gene Signature in Melanoma Associated With Clinical Activity
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
- Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations
- Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy
- A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3
- Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
- Differential Regulation of Murine T Lymphocyte Subsets
- Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
- Evidence implicating utilization of different T cell receptor-associated signaling pathways by TH1 and TH2 clones.
- Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy